MedPath

Effects of Anaesthesia On Immune Suppression, Inflammation AND Metastasis Of Breast Cancer.

Not Applicable
Conditions
Health Condition 1: C50- Malignant neoplasm of breast
Registration Number
CTRI/2020/11/028826
Lead Sponsor
Chittaranjan National Cancer Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Newly diagnosed breast cancer (Unilateral) confirmed with histopathological diagnosis. 2. ASA I (Normal healthy patient) & ASA II (Patient with mild systemic disease)

3. T1 N0, T2N0, T3N0, T1N1, T2N1, T3N1 Mx

4. Both male & female

6. Duration of surgery <= to 2 hrs.

Exclusion Criteria

1. Patient having any kind of anticancer treatment

2. Active bleeding

3. Recent history of massive blood transfusion

4. Pregnant & Lactating woman

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency and activity of NK cellsTimepoint: 1. Intra-operatively after 1 hour of incision. <br/ ><br>2. 48 hours post-operatively
Secondary Outcome Measures
NameTimeMethod
1. Frequency of T-lymphocytes, B-lumphocytes. <br/ ><br>2. Expression of TNF-alpha, IL-6, IL- 8, IL-10, MMP-2, MMP-9.Timepoint: 1. Intra-operatively after 1 hour of incision. <br/ ><br>2. 48 hours post-operatively
© Copyright 2025. All Rights Reserved by MedPath